HOME >> BIOLOGY >> NEWS
Fox Chase Cancer Center researchers identify significant smoking-induced genetic alteration

A Fox Chase Cancer Center researcher and her colleagues have identified a genetic alteration that occurs 13 times more frequently in lung tissue of mice exposed to tobacco smoke. The frequency of this genetic alteration and its role in estrogen metabolism could help researchers understand why women who smoke are more susceptible to lung cancer. These findings were presented today at the 95th Annual Meeting of the American Association for Cancer Research in Orlando, Fla.

The researchers found 53 smoking-induced genetic alterations in mice exposed to tobacco smoke compared to unexposed controls. The most notable finding was the 13-fold overexpression of the enzyme CYP1B1.

"Our research demonstrates that this alteration isn't present in the lung tissue prior to tobacco exposure," said Fox Chase researcher Sibele I. Meireles, Ph.D., lead author of the research. "Since we know this alteration is present in human lung tumors, it could be a target for chemopreventive intervention in people at high risk for lung cancer--in particular, active smokers."

Because CYP1B1 activates estradiol, one of the body's natural estrogen hormones, this finding could also help researchers understand more about why female smokers are more susceptible to lung cancer than male smokers.

"The overexpression of CYP1B1 poses an interesting question about gender differences in the development of lung cancer," said Meireles "We hadn't intended to look at gender differences in this study, but this finding about an enzyme so important to estrogen metabolism once again raises the issue of whether estrogen has a role in promoting lung cancer, as it does in breast and ovarian cancer."

The American Cancer Society estimates that 173,770 people will be diagnosed with lung cancer in 2004 and an estimated 160,440 people will die of the disease this year.

Meireles is a postdoctoral associate in the laboratory of cell biologist Margie L. Clapper, Ph.D., director of ch
'"/>

Contact: Karen Carter Mallet
karen.carter@fccc.edu
215-728-2700
Fox Chase Cancer Center
29-Mar-2004


Page: 1 2

Related biology news :

1. Fox Chase Cancer Centers Alfred Knudson Jr. named 2004 Kyoto Prize winner
2. Fox Chase discovery may help physicians diagnose, treat devastating childhood disease
3. Wilex & Fox Chase Cancer Center begin trial w/ novel compound targeting tumor invasion & metastasis
4. Fox Chase Cancer Center research shows kidney cancer can be diagnosed in urine
5. Fox Chase Cancer Center research reveals how COX-2 causes ovarian cancer
6. Fox Chase Cancer Center research shows kidney cancer can be diagnosed in urine
7. Fox Chase Cancer Center researcher develops new model for studying prions mad cow disease
8. Fox Chase Cancer Center study: Novel DNA-repair gene mutation can cause resistance to cancer drugs
9. NIH funds Breast Cancer and the Environmental Research Center at Fox Chase Cancer Center
10. Fox Chase Cancer Center researchers make significant discovery about function of p53
11. Fox Chase Cancer Center receives grant to study possible link between measles vaccine and autism

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/18/2018)... ... 18, 2018 , ... CP Merritt is a national champion Arabian horse that ... however in 2006, he had a medical setback that caused him to limp at ... from cartilage degeneration in his right rear fetlock. Such an injury could be ...
(Date:12/13/2018)... ... December 12, 2018 , ... Illumina, Kaiser Permanente, ResMed and ... The San Diego-based team-building and cooking events company has hosted an impressive guest ... cooking challenges. , Each group who visits receives a completely customized experience, ...
(Date:12/6/2018)... ... December 06, 2018 , ... Stewart has been ... contract services, throughout his career. During his recent five-year tenure with InSphero he ... established the commercial laboratory operations in Brunswick, Maine. Through these experiences, Stewart has ...
Breaking Biology News(10 mins):
(Date:1/8/2019)... ... ... The American Society of Gene and Cell Therapy’s (ASGCT) first class ... of industry leaders identified by the ASGCT board of directors. In total, the Society ... ASGCT members designing transformative pilot studies in gene and cell therapy as they prepare ...
(Date:1/4/2019)... ... January 02, 2019 , ... ... detect precancer and cancer cells in blood, has been named as a partner ... global biotech company developing cell therapies for cancer treatment, will use CellMax Life’s ...
(Date:12/19/2018)... ... 2018 , ... RURO, Inc., a leading provider of information ... The new release enhances the latest version of Limfinity®, RURO’s software framework, and ... , Validation protocols, and their execution, are critical for software systems scrutinized by ...
(Date:12/14/2018)... ... 2018 , ... NOVA OCULUS PARTNERS, LLC, and its Canadian ... immediately begin a clinical patient trial in Edmonton using their pioneering technology for ... has granted what is called an Investigational Testing Authorization for the trial, while ...
Breaking Biology Technology:
Cached News: